4-(dimethylamino)-N,N-dimethylbutanamide

Catalog No.: 
ACTVRY455
CAS No.: 
62782-20-1
Molecular Formula: 
C8H18N2O
Molecular Weight: 
158.24
4-(dimethylamino)-N,N-dimethylbutanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$182.00In stockInquiry
250mg98%$303.00In stockInquiry
500mg98%$433.00In stockInquiry
1g98%$619.00In stockInquiry
5g98%$1856.00In stockInquiry
10g98%$3093.00InquiryInquiry
25g98%$6185.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(dimethylamino)-N,N-dimethylbutanamide
IUPAC Name4-(dimethylamino)-N,N-dimethylbutanamide
Molecular FormulaC8H18N2O
Molecular Weight158.24
SMILESCN(C)CCCC(=O)N(C)C
InChI KeyJADJDUSHBTYYNQ-UHFFFAOYSA-N
SynonymButanamide, 4-(dimethylamino)-N,N-dimethyl-;4-(dimethylamino)-N,N-dimethyl-butanamide;4-(dimethylamino)-N,N-dimethyl-butanamide - [D87120]
CAS No.62782-20-1
PubChem CID57674731

Synthetic Route by SureRoute

1. ACTVRY455 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKAOG580 route compound structure diagram
    ACKAOG580693-11-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTVRY455 route product structure diagram
    ACTVRY45562782-20-1In Stock
Inquiry

2. ACTVRY455 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSODN316 route compound structure diagram
    ACSODN31622813-58-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTVRY455 route product structure diagram
    ACTVRY45562782-20-1In Stock
Inquiry

3. ACTVRY455 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTVRY455 route product structure diagram
    ACTVRY45562782-20-1In Stock
Inquiry

Comments (0)